Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT...
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?
About this item
Full title
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?
Author / Creator
Publisher
England: Oxford University Press
Journal title
European heart journal. Cardiovascular pharmacotherapy, 2025-01, Vol.11 (1), p.3-4
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Alternative Titles
Full title
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3122635502
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3122635502
Other Identifiers
ISSN
2055-6837,2055-6845
E-ISSN
2055-6845
DOI
10.1093/ehjcvp/pvae082
